دورية أكاديمية
Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.
| العنوان: | Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. |
|---|---|
| المؤلفون: | Cannioto R; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York., LaMonte MJ; Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, New York., Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut., Hong CC; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York., Sucheston-Campbell LE; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York., Eng KH; Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, New York., Brian Szender J; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, New York., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schmalfeldt B; Department of Gynecology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Klapdor R; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Niedersachsen, Germany., Gower E; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York. Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, New York., Minlikeeva AN; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York. Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo, New York., Zirpoli GR; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York., Bandera EV; Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Berchuck A; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina., Cramer D; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Doherty JA; Department of Epidemiology, The Geisel School of Medicine at Dartmouth Medical, Hanover, New Hampshire., Edwards RP; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Ovarian Cancer Center of Excellence, Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania., Fridley BL; Biostatistics and Informatics Shared Resource, University of Kansas Medical Center, Kansas City, Kansas., Goode EL; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota., Goodman MT; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Hogdall E; Department of Virus, Lifestyle, and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark., Hosono S; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan., Jensen A; Department of Virus, Lifestyle, and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark., Jordan S; Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia. Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Kjaer SK; Department of Virus, Lifestyle, and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark. Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Matsuo K; Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan., Ness RB; The University of Texas School of Public Health, Houston, Texas., Olsen CM; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Olson SH; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Leigh Pearce C; Department of Epidemiology, University of Michigan, Ann Arbor, Michigan., Pike MC; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Anne Rossing M; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington., Szamreta EA; Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Thompson PJ; Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Tseng CC; Department of Preventive Medicine, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California., Vierkant RA; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota., Webb PM; Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Wentzensen N; Division of Cancer Epidemiology and Genetics, NCI, Bethesda, Maryland., Wicklund KG; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington., Winham SJ; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota., Wu AH; Department of Preventive Medicine, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California., Modugno F; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Ovarian Cancer Center of Excellence, Women's Cancer Research Program, Magee-Women's Research Institute and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania., Schildkraut JM; Department of Public Health Sciences, The University of Virginia, Charlottesville, Virginia., Terry KL; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Kelemen LE; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina., Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, New York. kirsten.moysich@roswellpark.org. |
| مؤلفون مشاركون: | Australian Ovarian Cancer Study Group |
| المصدر: | Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2016 Jul; Vol. 25 (7), pp. 1114-24. Date of Electronic Publication: 2016 May 06. |
| نوع المنشور: | Journal Article; Meta-Analysis; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9200608 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7755 (Electronic) Linking ISSN: 10559965 NLM ISO Abbreviation: Cancer Epidemiol Biomarkers Prev Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Philadelphia, PA : American Association for Cancer Research, c1991- |
| مواضيع طبية MeSH: | Exercise* , Sedentary Behavior*, Neoplasms, Glandular and Epithelial/*epidemiology , Ovarian Neoplasms/*epidemiology, Adult ; Carcinoma, Ovarian Epithelial ; Case-Control Studies ; Female ; Humans ; Logistic Models ; Neoplasms, Glandular and Epithelial/etiology ; Ovarian Neoplasms/etiology ; Recreation/physiology ; Risk Factors |
| مستخلص: | Background: Despite a large body of literature evaluating the association between recreational physical activity and epithelial ovarian cancer (EOC) risk, the extant evidence is inconclusive, and little is known about the independent association between recreational physical inactivity and EOC risk. We conducted a pooled analysis of nine studies from the Ovarian Cancer Association Consortium to investigate the association between chronic recreational physical inactivity and EOC risk. Methods: In accordance with the 2008 Physical Activity Guidelines for Americans, women reporting no regular, weekly recreational physical activity were classified as inactive. Multivariable logistic regression was utilized to estimate the ORs and 95% confidence intervals (CI) for the association between inactivity and EOC risk overall and by subgroups based upon histotype, menopausal status, race, and body mass index. Results: The current analysis included data from 8,309 EOC patients and 12,612 controls. We observed a significant positive association between inactivity and EOC risk (OR = 1.34; 95% CI, 1.14-1.57), and similar associations were observed for each histotype. Conclusions: In this large pooled analysis examining the association between recreational physical inactivity and EOC risk, we observed consistent evidence of an association between chronic inactivity and all EOC histotypes. Impact: These data add to the growing body of evidence suggesting that inactivity is an independent risk factor for cancer. If the apparent association between inactivity and EOC risk is substantiated, additional work via targeted interventions should be pursued to characterize the dose of activity required to mitigate the risk of this highly fatal disease. Cancer Epidemiol Biomarkers Prev; 25(7); 1114-24. ©2016 AACR. (©2016 American Association for Cancer Research.) |
| References: | Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2000-8. (PMID: 23966580) Cancer Causes Control. 2009 Jul;20(5):765-73. (PMID: 19116765) Physiology (Bethesda). 2013 Sep;28(5):330-58. (PMID: 23997192) Endocr Relat Cancer. 2008 Dec;15(4):1055-60. (PMID: 18667686) Cancer Res. 2011 Dec 15;71(24):7463-70. (PMID: 22025564) J Natl Cancer Inst. 2014 Feb;106(2):djt431. (PMID: 24503200) PLoS One. 2012;7(5):e36345. (PMID: 22590532) Cancer Prev Res (Phila). 2013 Aug;6(8):811-21. (PMID: 23761272) Int J Epidemiol. 2013 Apr;42(2):579-89. (PMID: 23569193) Br J Sports Med. 2011 Mar;45(3):203-8. (PMID: 20484314) Int J Cancer. 2008 Jan 1;122(1):170-6. (PMID: 17721999) J Clin Epidemiol. 1990;43(11):1123-9. (PMID: 2243250) PLoS One. 2014 Aug 12;9(8):e104630. (PMID: 25115836) Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1350-9. (PMID: 26126627) Int J Dev Biol. 2012;56(10-12):959-67. (PMID: 23417417) Ann Epidemiol. 2011 Mar;21(3):178-87. (PMID: 21296269) Control Clin Trials. 1986 Sep;7(3):177-88. (PMID: 3802833) J Natl Cancer Inst. 1999 Sep 1;91(17):1459-67. (PMID: 10469746) Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2548-56. (PMID: 18086757) Lancet. 2012 Jul 21;380(9838):247-57. (PMID: 22818937) Cancer Immunol Res. 2014 Apr;2(4):332-40. (PMID: 24764580) Gynecol Oncol. 2015 Jun;137(3):559-73. (PMID: 25797080) Clin Immunol. 2013 Oct;149(1):97-110. (PMID: 23948613) Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1094-100. (PMID: 25873577) BMC Womens Health. 2011 Sep 23;11:40. (PMID: 21943063) Tumour Biol. 2014 Nov;35(11):11065-73. (PMID: 25095977) Int J Cancer. 2016 Feb 15;138(4):843-52. (PMID: 26335147) Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2321-30. (PMID: 18006921) Fertil Steril. 2004 Jul;82(1):186-95. (PMID: 15237010) BMJ. 2003 Sep 6;327(7414):557-60. (PMID: 12958120) Cancer Causes Control. 2010 Dec;21(12):2183-94. (PMID: 20827504) Cancer Res. 2005 Jul 1;65(13):5974-81. (PMID: 15994977) Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2691-709. (PMID: 20833969) N Z Med J. 2008 Jan 25;121(1268):U2897. (PMID: 18256708) Cancer. 2004 Apr 1;100(7):1515-21. (PMID: 15042687) Clin Cancer Res. 2008 Feb 15;14(4):1065-72. (PMID: 18258665) Percept Mot Skills. 2000 Oct;91(2):593-602. (PMID: 11065323) Proc Natl Acad Sci U S A. 2005 May 24;102(21):7677-82. (PMID: 15890779) Ann Epidemiol. 2011 Mar;21(3):188-96. (PMID: 21109450) BMC Cancer. 2013 Jan 22;13:28. (PMID: 23339562) Am J Public Health. 1991 Jun;81(6):771-3. (PMID: 2029054) Arch Intern Med. 2004 Nov 8;164(20):2253-9. (PMID: 15534163) Cancer Causes Control. 2012 Dec;23(12):1985-94. (PMID: 23065074) Lancet Oncol. 2012 Apr;13(4):385-94. (PMID: 22361336) PLoS One. 2013 Jul 26;8(7):e69631. (PMID: 23922763) Cancer Prev Res (Phila). 2015 Feb;8(2):105-10. (PMID: 25416409) Cancer Prev Res (Phila). 2014 Jan;7(1):9-11. (PMID: 24346343) Endocr Relat Cancer. 2013 Mar 22;20(2):251-62. (PMID: 23404857) Sports Med. 2001 Feb;31(2):91-100. (PMID: 11227981) Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1738-41. (PMID: 16985038) Cancer Causes Control. 2004 Feb;15(1):83-9. (PMID: 14970738) Cancer Causes Control. 2013 May;24(5):989-1004. (PMID: 23456270) Gynecol Oncol. 2013 May;129(2):353-7. (PMID: 23402904) Am J Epidemiol. 2006 Apr 15;163(8):709-16. (PMID: 16495470) Epidemiology. 2012 Mar;23(2):311-9. (PMID: 22252409) Asian Pac J Cancer Prev. 2013;14(7):3993-4003. (PMID: 23991944) Int J Gynecol Cancer. 2015 May;25 Suppl 1:67. (PMID: 25955943) Am J Cancer Res. 2013;3(1):21-33. (PMID: 23359288) J Am Coll Cardiol. 2005 May 17;45(10):1563-9. (PMID: 15893167) Am J Epidemiol. 1993 Dec 1;138(11):923-36. (PMID: 8256780) Am J Prev Med. 2005 Nov;29(4):256-64. (PMID: 16242587) Eur J Cancer. 2010 Sep;46(14):2593-604. (PMID: 20843488) Cancer Causes Control. 2015 Nov;26(11):1691-7. (PMID: 26335264) Res Q Exerc Sport. 2012 Dec;83(4):587-91. (PMID: 23367822) Exerc Immunol Rev. 2011;17:6-63. (PMID: 21446352) |
| معلومات مُعتمدة: | UL1 TR001863 United States TR NCATS NIH HHS; K22 CA138563 United States CA NCI NIH HHS; R01 CA080742 United States CA NCI NIH HHS; R01 CA074850 United States CA NCI NIH HHS; P50 CA105009 United States CA NCI NIH HHS; K07 CA080668 United States CA NCI NIH HHS; P30 CA008748 United States CA NCI NIH HHS; R01 CA188900 United States CA NCI NIH HHS; R03 CA115195 United States CA NCI NIH HHS; K01 LM012100 United States LM NLM NIH HHS; P01 CA017054 United States CA NCI NIH HHS; P30 CA016359 United States CA NCI NIH HHS; K07 CA095666 United States CA NCI NIH HHS; R01 CA112523 United States CA NCI NIH HHS; N01 CN025403 United States CN NCI NIH HHS; N01 PC067010 United States PC NCI NIH HHS; P50 CA159981 United States CA NCI NIH HHS; R25 CA113951 United States CA NCI NIH HHS; R01 CA087538 United States CA NCI NIH HHS; P30 CA046592 United States CA NCI NIH HHS; P30 CA072720 United States CA NCI NIH HHS; R01 CA095023 United States CA NCI NIH HHS; R03 CA113148 United States CA NCI NIH HHS; R01 CA058598 United States CA NCI NIH HHS; P30 CA014089 United States CA NCI NIH HHS; R01 CA083918 United States CA NCI NIH HHS; R01 CA054419 United States CA NCI NIH HHS; R01 CA122443 United States CA NCI NIH HHS |
| تواريخ الأحداث: | Date Created: 20160520 Date Completed: 20180117 Latest Revision: 20240615 |
| رمز التحديث: | 20240615 |
| مُعرف محوري في PubMed: | PMC4930728 |
| DOI: | 10.1158/1055-9965.EPI-15-1330 |
| PMID: | 27197285 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1538-7755 |
|---|---|
| DOI: | 10.1158/1055-9965.EPI-15-1330 |